Literature DB >> 6504705

Sequence homologies in the region preceding the transcription initiation site of the liver estrogen-responsive vitellogenin and apo-VLDLII genes.

P Walker, J E Germond, M Brown-Luedi, F Givel, W Wahli.   

Abstract

In the liver of oviparous vertebrates vitellogenin gene expression is controlled by estrogen. The nucleotide sequence of the 5' flanking region of the Xenopus laevis vitellogenin genes A1, A2, B1 and B2 has been determined. These sequences have been compared to each other and to the equivalent region of the chicken vitellogenin II and apo-VLDLII genes which are also expressed in the liver in response to estrogen. The homology between the 5' flanking region of the Xenopus genes B1 and B2 is higher than between the corresponding regions of the other closely related genes A1 and A2. Four short blocks of sequence homology which are present at equivalent positions in the vitellogenin genes of both Xenopus laevis and chicken are characterized. A short sequence with two-fold rotational symmetry (GGTCANNNTGACC) was found at similar positions upstream of the five vitellogenin genes and is also present in two copies close to the 5' end of the chicken apo-VLDLII gene. The possible functional significance of this sequence, common to liver estrogen-responsive genes, is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6504705      PMCID: PMC320402          DOI: 10.1093/nar/12.22.8611

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  44 in total

1.  Organization and sequence studies of the 17-piece chicken conalbumin gene.

Authors:  M Cochet; F Gannon; R Hen; L Maroteaux; F Perrin; P Chambon
Journal:  Nature       Date:  1979-12-06       Impact factor: 49.962

2.  Isolation and characterization of genomic clones covering the chicken vitellogenin gene.

Authors:  A C Arnberg; F C Meijlink; J Mulder; E F van Bruggen; M Gruber; A B Geert
Journal:  Nucleic Acids Res       Date:  1981-07-24       Impact factor: 16.971

3.  The ovalbumin gene-sequence of putative control regions.

Authors:  C Benoist; K O'Hare; R Breathnach; P Chambon
Journal:  Nucleic Acids Res       Date:  1980-01-11       Impact factor: 16.971

4.  Comparative analysis of the structural organization of two closely related vitellogenin genes in X. laevis.

Authors:  W Wahli; I B Dawid; T Wyler; R Weber; G U Ryffel
Journal:  Cell       Date:  1980-05       Impact factor: 41.582

5.  A system for shotgun DNA sequencing.

Authors:  J Messing; R Crea; P H Seeburg
Journal:  Nucleic Acids Res       Date:  1981-01-24       Impact factor: 16.971

6.  Steroid hormone regulation of ovalbumin and conalbumin gene transcription. A model based upon multiple regulatory sites and intermediary proteins.

Authors:  R D Palmiter; E R Mulvihill; J H Shepherd; G S McKnight
Journal:  J Biol Chem       Date:  1981-08-10       Impact factor: 5.157

7.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Albumin phylogeny for clawed frogs (Xenopus).

Authors:  C A Bisbee; M A Baker; A C Wilson; I Haji-Azimi; M Fischberg
Journal:  Science       Date:  1977-02-25       Impact factor: 47.728

9.  Vitellogenesis and the vitellogenin gene family.

Authors:  W Wahli; I B Dawid; G U Ryffel; R Weber
Journal:  Science       Date:  1981-04-17       Impact factor: 47.728

10.  Glucocorticoid regulation of mouse mammary tumor virus: identification of a short essential DNA region.

Authors:  E Buetti; H Diggelmann
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

View more
  71 in total

1.  Estrogen receptor level determines sex-specific in vitro transcription from the Xenopus vitellogenin promoter.

Authors:  B Corthésy; F X Claret; W Wahli
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

2.  Activation of chromosomal vitellogenin genes in Xenopus oocytes by pure estrogen receptor and independent activation of albumin genes.

Authors:  E A McKenzie; N A Cridland; J Knowland
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

Review 3.  Impact of sex hormone metabolism on the vascular effects of menopausal hormone therapy in cardiovascular disease.

Authors:  Durr-e-Nayab Masood; Emir C Roach; Katie G Beauregard; Raouf A Khalil
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

4.  Synergistic transcriptional activation by CTF/NF-I and the estrogen receptor involves stabilized interactions with a limiting target factor.

Authors:  E Martinez; Y Dusserre; W Wahli; N Mermod
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

5.  Binding of the estrogen receptor DNA-binding domain to the estrogen response element induces DNA bending.

Authors:  A M Nardulli; D J Shapiro
Journal:  Mol Cell Biol       Date:  1992-05       Impact factor: 4.272

6.  Identification of novel steroid-response elements.

Authors:  Z Nawaz; M J Tsai; D P McDonnell; B W O'Malley
Journal:  Gene Expr       Date:  1992

7.  Isolation of estrogen receptor-binding sites in human genomic DNA.

Authors:  S Inoue; S Kondo; M Hashimoto; T Kondo; M Muramatsu
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

8.  In simple synthetic promoters YY1-induced DNA bending is important in transcription activation and repression.

Authors:  J Kim; D J Shapiro
Journal:  Nucleic Acids Res       Date:  1996-11-01       Impact factor: 16.971

9.  Binding of type II nuclear receptors and estrogen receptor to full and half-site estrogen response elements in vitro.

Authors:  C M Klinge; D L Bodenner; D Desai; R M Niles; A M Traish
Journal:  Nucleic Acids Res       Date:  1997-05-15       Impact factor: 16.971

10.  Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists.

Authors:  A Mahfoudi; E Roulet; S Dauvois; M G Parker; W Wahli
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.